Mark G. Currie

2018

In 2018, Mark G. Currie earned a total compensation of $2.4M as Former Senior Vice President, Chief Scientific Officer and President of R&D at Ironwood Pharmaceuticals, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$242,500
Option Awards$1,424,289
Salary$485,000
Stock Awards$231,360
Other$62,271
Total$2,445,420

Currie received $1.4M in option awards, accounting for 58% of the total pay in 2018.

Currie also received $242.5K in non-equity incentive plan, $485K in salary, $231.4K in stock awards and $62.3K in other compensation.

Rankings

In 2018, Mark G. Currie's compensation ranked 4,756th out of 14,244 executives tracked by ExecPay. In other words, Currie earned more than 66.6% of executives.

ClassificationRankingPercentile
All
4,756
out of 14,244
67th
Division
Manufacturing
1,789
out of 5,765
69th
Major group
Chemicals And Allied Products
649
out of 2,128
70th
Industry group
Drugs
546
out of 1,817
70th
Industry
Pharmaceutical Preparations
421
out of 1,391
70th
Source: SEC filing on April 26, 2019.

Currie's colleagues

We found five more compensation records of executives who worked with Mark G. Currie at Ironwood Pharmaceuticals in 2018.

2018

Peter Hecht

Ironwood Pharmaceuticals

Chief Executive Officer

2018

William Huyett

Ironwood Pharmaceuticals

Chief Operating Officer

2018

Thomas McCourt

Ironwood Pharmaceuticals

President

2018

Halley Gilbert

Ironwood Pharmaceuticals

Chief Administrative Officer

2018

Gina Consylman

Ironwood Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like